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Abstract
Background: Diabetes is thought to accelerate cardiovascular disease depending on the type of diet. This study in
diabetic subjects was performed to investigate the metabolic, inflammatory and cardiovascular effects of nutritional
components typically present in a Western, Mediterranean or high glycaemic diet.
Methods: Streptozotocin-diabetic pigs (~45 kg) were fed for 10 weeks supplemental (40% of dietary energy)
saturated fat/cholesterol (SFC), unsaturated fat (UF) or starch (S) in an eucaloric dietary intervention study.
Results: Fasting plasma total, LDL and HDL cholesterol concentrations were 3-5 fold higher (p < 0.01) in SFC
compared to UF and S pigs. Fasting plasma NEFA concentrations (mmol/L) were highest (p < 0.05) in SFC (1.09 ±
0.17), intermediate in UF (0.80 ± 0.14) and lowest in S pigs (0.58 ± 0.14) whereas plasma glucose (~13 mmol/L),
triglyceride (~0.5 mmol/L) and insulin (~24 pmol/L) concentrations were comparable among SFC, UF and S pigs.
The postprandial response area under the curves (AUC, 0-4 h) for glucose but not for insulin and triglyceride
responses were intermediate in SFC (617 ± 144) and lowest (p < 0.05) in UF (378 ± 157) compared to S pigs
(925 ± 139). Fasting hepatic glucose production, hepatic and peripheral insulin sensitivity and blood pressure were
not different among pigs. C-reactive protein (CRP) concentrations (mg/L) were highest (p < 0.05) in SFC (25 ± 4),
intermediate in S (21 ± 3) and lowest in UF pigs (14 ± 2). Liver weights, liver and muscle triglyceride
concentrations, and the surface area of aorta fatty streaks were highest (p < 0.01) in SFC pigs. A positive
correlation between postprandial plasma CRP and aorta fatty streaks was observed in SFC pigs (R2 = 0.95).
Retroperitoneal fat depot weight (g) was intermediate in SFC (260 ± 72), lowest in S (135 ± 51) and highest
(p < 0.05) in UF (571 ± 95) pigs.
Conclusion: Dietary saturated fat/cholesterol induces inflammation, atherosclerosis and ectopic fat deposition
whereas an equally high dietary unsaturated fat load does not induce these abnormalities and shows beneficial
effects on postprandial glycaemia in diabetic pigs.
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Background
The impact of an excess in dietary fats and carbohy-
drates on metabolic control, inflammation and cardio-
vascular disease has been studied and discussed in
normal and (pre)diabetic subjects in both human [1-4]
and animal studies [5-7]. In general, excessive dietary
saturated fats and cholesterol increase the risk for the
development of obesity, diabetes and cardiovascular dis-
eases [6,8-10] while dietary unsaturated fats are consid-
ered less harmful and do not impose an increased risk
for the development of diabetes and cardiovascular dis-
eases [1,2,6]. Dietary carbohydrates, in the form of
starches, have a high glycaemic load and thereby worsen
postprandial glucose, stimulate insulin secretion and de
novo lipogenesis [11-14].
Most studies on the longer term (months) effects of
dietary components have been carried out in normal or
glucose intolerant individuals but limited information is
available in diabetic subjects on metabolic control,
inflammation, cardiovascular abnormalities and body
composition [2,12,13,15].
Longer term studies in diabetic humans are difficult to
perform because adherence to the prescribed diets has
proven to be extremely difficult [16] and because dietary
effects on the pathophysiology of diabetes are usually
small with respect to metabolic control, insulin sensitiv-
ity, inflammation and cardiovascular diseases [17,18]. In
addition, longer term studies are usually necessary to
disclose any dietary effects on the pathophysiology of
diabetes because part of the dietary effects are caused by
changes in body composition. This can partly be over-
come by studying animal models which are representa-
tive for the human situation, are highly homogenous
and are kept under strictly standardized experimental
conditions.
We have developed a pig model for diabetes mellitus
type 2 in humans which is characterized by insulin resis-
tance, hyperglycaemia as well as elevated plasma trigly-
ceride and NEFA concentrations. The diabetic pigs are
non-ketotic, anabolic and do not require insulin therapy
[19]. Pigs are like humans omnivores and as such, the
functionality of the gastrointestinal tract is comparable
between pigs and man and therefore the pig is an useful
animal model for the study of dietary components
[20,21]. This makes the pig particular useful when the
effect of diets is studied on diabetes accelerated dyslipi-
daemia and atherosclerosis [22-24]. Furthermore, coron-
ary arteries of diabetic pigs have been shown to express
low grade inflammation [25], a condition also described
in humans with type 2 diabetes mellitus [13,26,27].
The aim of this dietary intervention study was to char-
acterize and compare the medium/long-term (10 weeks)
pathogenic effects of eucaloric diets 1) both high in
supplemental fat, but differing in fat composition as
reflected by mainly saturated fats and cholesterol (SFC)
versus mainly unsaturated fats (UF) and 2) differing in
supplemental fat (SFC or UF) versus supplemental car-
bohydrate (starch, S), on pre- and postprandial hypergly-
caemia, lipidaemia and insulinaemia, on insulin
sensitivity, blood pressure, circulating pro-inflammatory
markers, retroperitoneal fat weight and on muscle, liver
and aorta lipid deposits in diabetic pigs.
Methods
The performed research is in compliance with the
ARRIVE guidelines on animal research [28]. Experimen-
tal protocols describing the management, surgical proce-
dures, and animal care were reviewed and approved by
the ASG-Lelystad Animal Care and Use Committee
(Lelystad, The Netherlands).
Animals, housing, diets and surgery
Domestic (Landrace × Yorkshire, D-line) pigs (barrows
with an initial age and body weight of ~11 weeks and
~30 kg, respectively) were obtained (Bastiaanse, Espel,
The Netherlands) and kept in specially designed meta-
bolic pens (1.15 × 1.35 m) and adapted to the light/dark
cycle (lights on at 05:00 h and off at 19:00 h) and a feed-
ing schedule. Pigs were weighed weekly and the meal size
was adjusted to the individual pig’s weight. The pigs were
fed 2.5-fold maintenance requirements for gross energy
(GE) as established in a normal pig. This corresponded
with a feeding level of 1045 kJ GE kg-1 BW0.75 (metabolic
weight of the pigs) per day and is sufficient to ensure
moderate growth in normal pigs [29].
The pigs were fed a commercial pig diet (5% crude fat,
16% crude protein, 41% starch and sugars, 20% non-starch
polysaccharides, 6% ash and 12% water; Startbrok; Agri-
firm, Meppel, The Netherlands) twice daily (at 06:00 and
16:00 h). Water was always available ad libitum. After
1 week, pigs were provided with a permanent blood vessel
catheter in the jugular vein, as previously described by us
[29,30]. One week after surgery, 21 pigs were treated with
streptozotocin (140 mg/kg) as described previously [19].
Two weeks thereafter, 3 pigs showed fasting plasma glu-
cose concentrations <10 mmol/L and were excluded from
the study. The remaining 18 pigs were balanced over the 3
diet groups, based on fasting hyperglycaemia. Composition
of the saturated fat/cholesterol, unsaturated fat and starch
enriched diets is shown in Table 1. The experimental
meals were fed twice daily (at 1045 kJ GE kg-1 BW0.75 per
day) for a duration of 10 weeks. In practical terms this
means that the pigs on the starch-enriched diet were fed
1.31-fold the amount (on weight basis, but equal in caloric
content) compared to the pigs on the fat-enriched diets in
order to match the energy intake of pigs among diets.
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Supplemental saturated fat plus cholesterol (SFC),
unsaturated fat (UF), or starch (S) content was 40% of
total dietary energy. SFC was derived from beef tallow
(i.e. ~55% saturated, ~35% mono-unsaturated, and ~10%
poly-unsaturated fatty acids) plus 1% cholesterol, UF
was derived from sunflower and rape oil (i.e. ~65%
poly-unsaturated, ~25% mono-unsaturated, and 10%
saturated fatty acids) and S was derived from pea starch,
representing components of a Western, Mediterranean
or high glycaemic diet, respectively.
Timeline
The timeline of the study is represented schematically in
Figure 1. In short, the 3 diets were fed to the pigs (n = 6
per diet group) for 10 weeks comprising the following
techniques and measurements: 1) daily food intake, 2)
weekly body weight, 3) quantitative collection of urine
(for determination of 24-h urinary glucose excretion) on
Mondays, Wednesdays and Fridays during the dietary
treatment, 4) at week 7, the pigs were provided with
permanent catheters in the jugular vein and carotid
artery, 5) at week 8, a meal tolerance test was performed
and intra-arterial blood pressure was recorded, 6) at
week 9, a hyperinsulinaemic euglycaemic clamp study
using 6,6-2H2-glucose infusion was performed and 7) at
week 10, pigs were killed by intravenous injection of
barbiturate (administered via the jugular catheter) for
tissue collection.
Meal tolerance test and blood pressure
During the one-week recovery period after surgery, the
pigs were habituated to the blood sampling and experi-
mental procedures. The carotid artery catheter was used
for blood sampling and registration of blood pressure.
During the blood sampling procedure, the catheters
were flushed with physiological saline and sealed off
with physiological saline containing 5 IU heparin per
mL. From experience we know that this sampling proce-
dure does not affect plasma NEFA concentrations.
Blood was sampled repeatedly before, during and after
the morning meal (-15, 0, 30, 60, 120, 240, 360, and 480
minutes from the start of feeding). Per sampling time
point, approximately 5 ml blood was sampled. The
responses of insulin, glucose and triglycerides were
assessed. In addition, the pre-and post-prandial levels of
C-reactive protein (CRP), haptoglobin, IL-6 and TNF-a
were determined on samples taken 15 minutes before
and 180 minutes after the start of feeding. Subsequent
to the meal tolerance test, the blood pressure and heart
rate were determined five hours post-prandially on a
Digital Electromanometer, Type 330 (Hugo Sachs Elek-
tronik KG, March-Hugstetten, Germany).
Hyperinsulinaemic euglycaemic clamp and 6,6-
2H2-glucose infusion
The jugular vein catheter was used for the infusion of
fluids and the carotid artery catheter was used for blood
Table 1 Composition of the experimental diets
Food ingredients Saturated fat diet plus cholesterol Unsaturated fat diet Starch diet
Milk protein (caseinate) 23.2 23.2 17.7
Fructose 9.2 9.2 7.1
Maltodextrin DE 19 30.8 30.8 23.6
Native pea starch 0.0 0.0 41.4
Total sugar and starch 40.0 40.0 72.1
Soy bean oil 0.0 0.0 2.7
Lecithin 0.0 1.5 0.0
Canola oil (rape oil/Lear) 0.0 2.7 0.0
Trisun 80, high oleic sunflower oil 0.0 23.0 0.0
Beef tallow 27.2 0.0 0.0
Total fat 27.2 27.2 2.7
Fiber: Fibrim 2000 9.4 9.4 7.3
Premix1 0.20 0.20 0.15
Cholesterol2 1.0 0.0 0.0
Total (%) 100.0 100.0 100.0
Gross Energy (GE; MJ/kg) 23.4 23.4 17.9
The per-cent of each ingredient contributing to the total amount of diet (= 100%) is listed. Energy intake was matched among dietary groups and therefore pigs
receiving the Starch diet were fed 1.32 times the amount of the high fat diet groups. Therefore the diets were homogenous except for starch or fat.
1 This vitamin and trace mineral premix contained per kg diet: vit. A (retinol) - 1750 IU; vit. D3 (cholecalciferol) - 200 IU; vit. E (tocopherol) - 11 IU; vit. K1
(phylloquinone) - 0.5 mg; vit. B1 (thiamin) - 1.0 mg; vit. B2 (riboflavin) - 4 mg; d-pantothenic acid - 9 mg; niacin (vit. B3, nicotinic acid) - 12.5 mg (available); biotin
(vit. H) - 50 μg; vit. B12 (cyanocobalamin) - 15 μg; folic acid (folacin) - 0.3 mg; vit. B6 (pyridoxin) - 1.5 mg; choline - 400 mg; Fe - 80 mg; Zn - 54 mg; Mn - 30 mg;
Co - 0.15 mg; I - 0.14 mg; Se - 0.25 mg; antioxidants (E310,320,321) - 50 mg; with maize starch as carrier.
2 Cholesterol has no energetic value and therefore 1 kg cholesterol was supplemented per 100 kg diet.
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sampling during the hyperinsulinaemic clamp study.
Preceding the insulin clamp, overnight fasting blood
samples were collected for determining the concentra-
tions of fructosamine, glucagon, cortisol, NEFA, total
cholesterol, LDL and HDL cholesterol and background
glucose enrichment.
After baseline samples, a prime (4.8 mg/kg)-continuous
(0.08 mg.kg-1.min-1) infusion of 6,6-2H2-glucose was admi-
nistered for 150 min. After an equilibration time, blood
samples were taken at 110, 120, 130, 140 and 150 min for
determination of glucose, 6,6-2H2-glucose enrichment (to
estimate fasting hepatic glucose production) and insulin.
Subsequently, insulin was infused (prime (34 mU/kg)-con-
tinuous (2 mU.kg-1.min-1)) for 6 hours. A variable infusion
of a 33% D-glucose solution was started to maintain
plasma glucose at euglycaemia (~5 mmol/L). Steady state
calculations were carried out during the last 40 minutes of
the clamp (t = 320, 330, 340, 350 and 360 min) and the
coefficients of variation for the insulin and glucose con-
centrations, and for the infusion rate of glucose were
determined. During the last 3 hours of the insulin clamp, a
prime (4.8 mg/kg)-continuous (0.08 mg.kg-1.min-1) infu-
sion of 6,6-2H2-glucose was superimposed to estimate 1)
insulin stimulated whole body glucose uptake (rate of dis-
appearance = Rd) and 2) insulin-inhibited hepatic glucose
production, as described before [19]. For this purpose
blood samples were taken at t 320, 330, 340, 350 and
360 min of the clamp.
Infusates: Insulin (Actrapid MC, porcine monocompo-
nent, Novo, Copenhagen, Denmark), 6,6-2H2-glucose
(Cambridge Isotope Laboratories, Inc, MA, USA) and
D-glucose (Merck, Darmstadt, Germany) were prepared
as sterile solutions and passed through a 0.22 μm Milli-
pore filter into sterile containers before use. Insulin was
diluted in a saline solution containing pig plasma (final
plasma concentration was 3%) in order to avoid sticking
of insulin to the plastic containers and tubings. 6,6-2H2-
glucose was dissolved in a saline solution and D-glucose
was dissolved in aqua dest.
Plasma, urine and tissue collection and analyses
Blood samples collected in heparinised (150 USP. U.
Lithium Heparin, 10 mL Venoject, Terumo, Leuven,
Belgium) or EDTA (ethylenediaminetetraacetic acid,
(0.47 mol/L EDTA, 10 mL Venoject, Terumo, Leuven,
Belgium) tubes were immediately chilled at 0°C on
water with ice, and centrifuged at 4°C for 10 minutes at
3000 rpm. Plasma aliquots were stored at -80°C for later
analyses. Urine was quantitatively collected per 24 hours
in buckets containing 0.5 grams Halamid-d (sodium-p-
toluenesulfonchloramide, Akzo Nobel Chemicals,
Amersfoort, The Netherlands) to prevent microbial
breakdown of glucose. Urine samples were stored at
-20°C for later glucose analyses. Muscle (m. iliopsoasis)
and liver were snap-frozen in liquid nitrogen and stored
at -80°C. Abdominal aorta was fixed in a 4% paraformal-
dehyde solution.
Plasma samples for determination of 6,6-2H2-glucose
enrichment were analyzed as described previously [19].
In short, glucose was extracted from plasma, derivatised,
and injected into a gas chromatograph/mass spectro-
meter system (HP 6890 series GC system and 5973
Mass Selective Detector, Palo Alto, CA, USA). Separa-
tion was achieved on a J&W scientific DB 17 capillary
column (30 m × 0.25 mm × 0.25 μm; Agilent Technolo-
gies Nederland BV, Amstelveen, The Netherlands). Iso-
topic enrichment was calculated as tracer-to- tracee
ratio after subtracting the isotopic enrichment of a back-
ground plasma sample. An aliquot of the 6,6-2H2-glu-
cose infusate was analyzed for the isotope concentration
to calculate the actual infusion rate for each infusion
experiment.
Start experimental diets
Jugular catheter
Weeks0-3
Tissue collection
10
Hyperinsulinaemic 
euglycaemic clamp 
9
Meal tolerance test
8
Carotid catheter
7
Urinary glucose excretion
Induction diabetes
Housing in metabolic cages
-1-2
Figure 1 Timeline of the study.
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Plasma glucose was analyzed with the Glucose liquiUV
mono kit (Human, Wiesbaden, Germany), plasma non-
esterified fatty acids were analyzed with the WAKO kit
(Neuss, Germany) and plasma triglycerides with a kit from
Human (Wiesbaden, Germany). Total, LDL and HDL cho-
lesterol concentrations in plasma were determined with
liquicolor kits (Human, Wiesbaden, Germany) and VLDL
cholesterol was calculated as total cholesterol minus LDL
and HDL cholesterol. Plasma insulin concentration was
measured using a Delfia assay (test kit by Perkin Elmer
Life Sciences Trust by Wallac Oy, Turku, Finland). This
specific pig insulin assay was validated using pig insulin
standards, as indicated before [30]. Plasma glucagon was
measured with a kit from Euro-Diagnostica (Arnhem, The
Netherlands), plasma cortisol with the Count-A-Count
Cortisol kit (DPC, Los Angeles, USA) and fructosamine by
a kit from Spinreact (Sant Esteve De Bas, Spain). Plasma
C-reactive protein (CRP), interleukin-6 (IL-6) and tumor
necrosis factor alpha (TNF-a) were analyzed with kits
(CRP-hs, Human, Wiesbaden, Germany; Haptoglobin,
Instruchemie, Delfzijl, The Netherlands; SW Interleukin 6,
IBL, Hamburg, Germany and SW TNF-alpha Elisa Kit,
Biosource Int, Camarillo, USA), respectively.
Ketones (acetoacetic acid) were determined in fresh
urine by a reagent strip test (Ketostix, Bayer Diagnostics,
Mijdrecht, The Netherlands).
Triglyceride concentrations in muscle and liver samples
were determined with the same kit as used for the plasma
samples, after saponification with an alkalin alcohol solu-
tion as previously described [31].
Aortic fatty streaks, as a marker of early atherosclero-
sis [22,24], (AHA class 2 lesion [32]), were quantified
with use of Sudan IV fat stain in sections of the abdom-
inal aorta ranging from the bifurcation of the renal
arteries to the bifurcation of the iliac arteries. The
stained aortas were then photographed and analyzed
with a microscopy image analysis system (Clemex tech-
nologies Inc., Quebec, Canada) as ratio of stained area
to total area.
Statistical analyses
Results are expressed as means ± SEM and the criterion
of statistical significance was set at p < 0.05. The data
were subjected to the analysis of variance procedure
(ANOVA) (for repeated measurements when applicable)
followed by the unpaired or paired student’s t-test of
Genstat 5 [33] for determination of differences between
or within the three dietary groups, respectively.
Results
Body composition
Final body weights were comparable among SFC, UF and
S pigs indicating that average food intake and urinary
glucose excretion were in balance during the course of
the study per diet group (Table 2). However, liver weights
and triglyceride concentrations were higher (p < 0.01) in
SFC pigs compared to UF and S pigs. Triglyceride con-
centration in muscle was highest (p < 0.01) in SFC pigs,
intermediate in UF and lowest in S pigs. Retroperitoneal
fat depot weight was intermediate in SFC (260 ± 72 g),
lowest in S (135 ± 51 g) and highest (p < 0.05) in UF (571
± 95) pigs.
Metabolic control
At the end of the dietary intervention, fasting plasma insu-
lin, glucagon, glucose, fructosamine and triglyceride con-
centrations were similar among all diabetic pigs (Tables 3
and 4). Fasting plasma total cholesterol, HDL, LDL and
VLDL concentrations were higher (p < 0.01) in SFC pigs
compared to UF and S pigs. The ratio of HDL/LDL cho-
lesterol was unchanged but the ratio of HDL/total choles-
terol was reduced (p < 0.05) in SFC and UF pigs compared
to S pigs (Table 4). Fasting plasma NEFA concentrations
were highest (p < 0.05) in SFC pigs, intermediate in UF
pigs and lowest S pigs (Table 4). Fasting hepatic glucose
production, insulin-inhibited hepatic glucose production
and insulin-stimulated whole body glucose uptake were
similar among diabetic pigs (Table 3). Coefficients of var-
iation of clamp plasma glucose, plasma insulin and glucose
infusion rate in SFC versus UF versus S pigs were 5 ±
2 versus 7 ± 3 versus 3 ± 1%, 11 ± 5 versus 7 ± 2 versus
8 ± 3% and 2 ± 1 versus 3 ± 1 versus 2 ± 1%, respectively.
The postprandial response area under the curves (0-4 h or
0-8 h) for glucose but not for insulin and triglyceride
responses were intermediate in SFC (617 ± 144 or 471 ±
122), lowest (p < 0.05) in UF (378 ± 157 or 292 ± 133) and
highest in S pigs (925 ± 139 or 724 ± 92 (Figures 2 and 3).
Inflammation
The fasting plasma concentrations of cortisol, haptoglo-
bin, IL-6 and TNF-a were not statistically different
between the diet groups (Table 4). By contrast, both
fasting and postprandial plasma C-reactive protein
(CRP) concentrations and meal-induced CRP responses
(Δ) were higher (p < 0.05) in SFC pigs compared to UF
pigs but not always higher compared to S pigs, i.e. fast-
ing plasma CRP concentration was similar in SFC and S
pigs (Figure 4).
Atherosclerosis and blood pressure
The surface area of aorta fatty streaks was higher (p <
0.001) in SFC pigs compared to UF and S pigs (Table 2).
Visualization of the fatty streaks in the abdominal aortas
of the three groups of pigs is presented in Figure 5. In
SFC pigs, a positive correlation between surface area of
aorta fatty streaks and postprandial plasma CRP concen-
tration was observed (R2 = 0.95, p < 0.001) (Figure 6).
Mean arterial, systolic and diastolic blood pressures were
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not statistically different between the diet groups
(Table 5).
Discussion
Main findings
Pigs on dietary SFC showed a more atherogenic plasma
profile with higher plasma NEFA concentrations, higher
liver weights and liver triglyceride concentrations, and
increased aorta fatty streak area compared to pigs on
dietary UF and S. The postprandial glucose, but not insu-
lin and triglyceride responses were intermediate in SFC
pigs, lowest in UF pigs and highest in S pigs, whereas
hepatic and whole body insulin sensitivities for glucose
metabolism were not significantly affected by the diets.
This indicates that the postprandial glucose intolerance
of S pigs compared to SFC and UF pigs is caused by an
increased systemic influx of dietary glucose after starch
digestion and not by insulin resistance. The mechanisms
behind the relative postprandial glucose intolerance in
SFC pigs compared to UF pigs are unknown. However,
several non-significant factors may contribute to the dif-
ference in postprandial glucose tolerance. Fasting and
insulin-inhibited hepatic glucose production during the
clamp were elevated by 16% (p = NS) and 50% (p = NS)
and early (30 min) postprandial insulin secretion was 2-
fold reduced (p = NS) in SFC pigs compared to UF pigs.
For the latter, it has been suggested that the degree of
saturation of fatty acids may have a negative influence on
insulin release by beta-cells in vitro [34]. Taken together,
these factors may add-up and act in concert to both
impair non-insulin-dependent and insulin-dependent
glucose tolerance in SFC pigs compared to UF pigs.
With respect to body composition, SFC pigs showed
increased muscle, liver and aorta fat deposits and a
reduced amount of retroperitoneal fat. The latter non-
ectopic depot of adipose tissue was largest in UF pigs,
indicating that body composition is most favourably
affected by the UF diet compared to the SFC diet in this
non-obese diabetic pig model. The UF diet is mainly
stored in adipose tissue and to a lesser extent in organs
and the vascular system. By contrast, the S pigs showed
the lowest muscle and liver fat deposits and a low
amount of retroperitoneal fat. This indicates that energy
storage in the form of fat is low from dietary S, both in
adipose and non-adipose tissue. The baseline markers of
systemic inflammation tended to be higher in SFC pigs,
but only baseline and postprandial CRP concentrations
reached levels of statistical significance. A strong correla-
tion was observed between postprandial plasma CRP and
aorta fatty streak area (R2 = 0.95, p < 0.001), suggesting
that postprandial CRP is a biomarker for atherosclerosis
in this diabetic pig model. This is one of the few pieces of
Table 2 Food intake, urinary glucose excretion, final body weights and tissue data of diabetic pigs fed saturated fat/
cholesterol or unsaturated fat or starch enriched diets
Saturated fat plus cholesterol diet Unsaturated fat diet Starch diet
Factual average food intake (MJ/day) 23.9 ± 1.3 25.0 ± 2.0 27.7 ± 0.9
Average urinary glucose excretion (MJ/day) 8.5 ± 1.0A 9.1 ± 1.1A 15.8 ± 2.1B
Final body weight (kg) 41 ± 3 45 ± 5 48 ± 7
Liver weight (kg) 1.47 ± 0.08A 1.12 ± 0.03B 1.11 ± 0.03B
Liver triglyceride concentration (g/kg) 49 ± 11A 27 ± 1B 21 ± 3B
Muscle triglyceride concentration (g/kg) 21 ± 4A 13 ± 3AB 8 ± 1B
Retroperitoneal fat weight (g) 260 ± 72AB 571 ± 95A 135 ± 51B
Surface area aorta fatty steaks (%) 17.9 ± 4.4A 0.03 ± 0.02B 0.14 ± 0.07B
A, B , data with different superscripts in the same row differ at p < 0.05.
Table 3 Fasting hepatic glucose production, insulin-stimulated whole body glucose uptake, insulin-inhibited hepatic
glucose production and plasma concentrations of metabolites and insulin in diabetic pigs fed saturated fat/cholesterol
or unsaturated fat or starch enriched diets
Saturated fat plus cholesterol diet Unsaturated fat diet Starch diet
Fasting plasma fructosamine (μmol/L) 449 ± 25 494 ± 62 558 ± 103
Fasting plasma glucose (mmol/L) 12.4 ± 0.4 14.4 ± 0.7 12.7 ± 1.6
Fasting plasma insulin (pmol/L) 23 ± 7 26 ± 7 22 ± 4
Fasting hepatic glucose production (mg.kg-1.min-1) 7.4 ± 0.8 6.4 ± 0.5 8.2 ± 2.0
Clamp plasma glucose (steady state, mmol/L) 5.7 ± 0.2 5.4 ± 0.2 5.4 ± 0.2
Clamp plasma insulin (steady state, pmol/L) 320 ± 27 409 ± 33 327 ± 33
Insulin-stimulated whole body glucose uptake (mg.kg-1.min-1) 10.0 ± 2.3 9.5 ± 2.1 10.8 ± 2.8
Insulin-inhibited hepatic glucose production
(mg.kg-1.min-1)
1.8 ± 0.2 1.2 ± 0.3 1.8 ± 0.1
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evidence that the inflammatory marker CRP is secondary
to the atheromatous process itself.
Taken together, these main findings indicate that diet-
ary saturated fat/cholesterol induces CRP associated
early atherosclerosis and ectopic fat deposition whereas
eucaloric unsaturated fat or starch do not induce these
abnormalities and unsaturated fat shows beneficial
effects on postprandial glycaemia in diabetic pigs.
Insulin resistance
After a 10-week intervention study, dietary composition
had no significant effect on insulin sensitivity in diabetic
pigs. This is in line with a 2-week intervention study in
type 2 diabetic patients [35]. In non-diabetic rodents
however, it is widely accepted that long-term feeding of
dietary saturated fats induces insulin resistance whereas
unsaturated fats increase insulin sensitivity [6]. This dis-
crepancy may be caused by the fact that insulin resistance
is already a prominent feature of diabetic humans [27]
and pigs [19] and any modest dietary effect on insulin
sensitivity does not come to expression in insulin resis-
tant individuals. For example, both liver [6] and skeletal
muscle [36] triglyceride concentrations have been shown
to affect insulin sensitivity but in the present study, the
diet-induced 2-fold variation in liver and skeletal muscle
triglyceride concentrations is insufficient to further mod-
ulate insulin resistance in diabetic pigs.
Inflammation
Fasting plasma concentrations of the acute phase protein
CRP were higher in diabetic pigs which were fed the SFC
diet compared to the UF diet but not to the S diet. This
underlines the anti-inflammatory effect of dietary UF
[37,38]. The pro-inflammatory effect of a diet rich in
saturated fats and cholesterol has been shown before in
Table 4 Fasting plasma concentrations of lipid metabolites, hormones and inflammatory markers in diabetic pigs fed
saturated fat/cholesterol or unsaturated fat or starch enriched diets
Saturated fat plus cholesterol diet Unsaturated fat diet Starch diet
NEFA (mmol/L) 1.09 ± 0.17A 0.80 ± 0.14AB 0.58 ± 0.14B
Triglycerides (mmol/L) 0.58 ± 0.17 0.51 ± 0.05 0.43 ± 0.11
Total cholesterol (mmol/L) 9.9 ± 1.2A 2.0 ± 0.1 B 1.7 ± 0.2 B
HDL cholesterol (mmol/L) 2.1 ± 0.2A 0.4 ± 0.0 B 0.5 ± 0.0 B
LDL cholesterol (mmol/L) 3.3 ± 0.3A 1.3 ± 0.1 B 1.1 ± 0.1 B
VLDL cholesterol (mmol/L) 4.5 ± 0.8A 0.2 ± 0.1 B 0.1 ± 0.0 B
Ratio HDL/LDL cholesterol 0.64 ± 0.08 0.35 ± 0.05 0.46 ± 0.03
Ratio HDL/total cholesterol 0.21 ± 0.01A 0.23 ± 0.02A 0.29 ± 0.01 B
Glucagon (pmol/L) 131 ± 25 114 ± 35 83 ± 10
Cortisol (nmol/L) 334 ± 44 284 ± 69 262 ± 50
Haptoglobin (pg/mL) 251 ± 132 394 ± 100 236 ± 52
IL-6 (pg/mL) 2224 ± 1102 818 ± 664 459 ± 270
TNF-a (pg/mL) 610 ± 289 394 ± 248 384 ± 135
A, B , data with different superscripts in the same row differ at p < 0.05.
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Figure 2 Postprandial curves (0-8 h) of plasma glucose (A),
triglycerides (B) and insulin (C) are shown for diabetic pigs
which were fed diets supplemented with starch (open circles),
unsaturated fats (black squares) or saturated fats with
cholesterol (black circles).
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non-diabetic humans [8,10] and in non-diabetic pigs
[39,40]. In our study, postprandial plasma CRP, but not
haptoglobin, IL-6 or TNF-a, positively correlated with
the severity of beginning atherosclerosis. It seems there-
fore that postprandial CRP concentrations, which were
increased 2-fold compared to fasting concentrations,
react strongly to vascular damage and/or atherosclerosis
[41]. Indeed, CRP has been proposed as a putative clinical
biomarker for atherosclerosis [42,43] serving a possible
protective role in the atherogenic process [44]. In diabetic
pigs which were fed a diet rich in UF, no increase in post-
prandial CRP was observed. This corresponds with the
absence of atherosclerosis in these diabetic pigs. The
beneficial mechanism of action of UF, but not SFC, may
be related to the affinity to bind to the nuclear peroxi-
some proliferator-activated receptor (PPAR), the same
pathway which is activated by the anti-diabetic drug thia-
zolidinedione (TZD) [27,45-47]. Therefore, dietary UF
can be regarded as a therapeutic agent to prevent some
of the abnormalities of type 2 diabetes.
Diabetic pig model
Fasting plasma insulin (~25 pmol/L), glucose (~13
mmol/L) and triglyceride (~0.5 mmol/L) concentrations
and a positive energy balance (body weight gain of
~1.5 kg/week) without the occurrence of ketosis indi-
cated a mild form of diabetes in the pigs. In a previous
paper we argued that the present insulin resistant pig
model resembled type 2 diabetes [19]. In addition to
these observations, we now showed that, after streptozo-
tocin treatment, the residual beta-cells of the pancreas
were able to increase insulin secretion ~5-7 fold upon a
meal-challenge. This indicates that a substantial endo-
genous insulin secretion capacity is still present in this
diabetic pig model.
Conclusion
When comparing dietary SFC, UF and S, dietary SFC
induces CRP-associated early atherosclerosis and ectopic
fat deposition whereas isoenergetic UF shows beneficial
effects on postprandial glycaemia, inflammation and
body composition in diabetic pigs.
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Figure 3 The postprandial response areas under the curve (Δ0-4
h) are depicted for plasma glucose (A), triglycerides (B) and
insulin (C) for supplemental starch (open bars), unsaturated fats
(striped bars) or saturated fats with cholesterol (black bars).
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Figure 4 Overnight fasting and postprandial (3 h) plasma C-
reactive protein (CRP) concentrations and the meal response
over fasting (Δ) are depicted for diabetic pigs which were fed
diets supplemented with starch (open bars), unsaturated fats
(striped bars) or saturated fats with cholesterol (black bars).
Means ± SEM. *p < 0.05.
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medial 
intimal 
vessel 
Figure 5 Images of typical examples of abdominal aorta Sudan IV fat staining of diabetic pigs, which were fed diets supplemented
with starch (top picture), unsaturated fats (middle), or saturated fats with cholesterol (bottom). Red intra-luminal staining indicates
presence of fatty streaks. Insert in bottom picture shows histological detail (hematoxylin-eosin staining) of fatty streak (4 × magnification). The
intimal area of this part of the vessel wall consists of multiple cellular layers with empty little spaces where fat was deposited.
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